Long Term Follow Up Protocol for NiCord®/CordIn™ (Omidubicel) Patients

Gamida Cell

Status: Completed

Conditions: Patients Transplanted With NiCord/CordIn (Omidubicel)

Treatments: Genetic: NiCord®/CordIn™ (omidubicel)

Study type: Observational

Funder types: Industry

Identifiers

NCT02039557

GC P# 04.01.020/030

Details and patient eligibility

About

This is an observational study that will monitor clinical outcomes of patients who have received a NiCord®/CordIn™ (omidubicel) transplant as part of a GC clinical interventional study and meet the eligibility criteria for this Long Term Follow Up study.

Enrollment: 33 patients

Sex: All

Ages: 2 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

• Anyone who has received a NiCord®/CordIn™ (omidubicel) transplant, completed study specific follow up, and has signed the consent for this study.

Exclusion Criteria

• None

Trial design

33 participants in 1 patient group

NiCord®/CordIn™ (omidubicel) transplanted

Description:

Anyone who signed the consent for this study received a NiCord®/CordIn™ (omidubicel) infusion as part of a GC clinical interventional study, and completed the interventional study Day 365 status assessment.

Treatment:

Genetic: NiCord®/CordIn™ (omidubicel)